-+ 0.00%
-+ 0.00%
-+ 0.00%

GLAUKOS CORPORATION - NO SERIOUS ADVERSE EVENTS OR DISCONTINUATIONS REPORTED IN THREE YEARS AFTER EPIOXA

Reuters·10/07/2026 20:07:19